Auxly Cannabis Group Inc. (XLY.TO)
CAD 0.08
(0.0%)
CAD 0.08
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 101.07 Million CAD | 6.99% |
| 2022 | 94.47 Million CAD | 12.7% |
| 2021 | 83.82 Million CAD | 65.03% |
| 2020 | 50.79 Million CAD | 508.19% |
| 2019 | 8.35 Million CAD | 1018.07% |
| 2018 | 747 Thousand CAD | -45.79% |
| 2017 | 1.37 Million CAD | 495.93% |
| 2016 | 231.23 Thousand CAD | -10.1% |
| 2015 | 257.2 Thousand CAD | -6.49% |
| 2014 | 275.05 Thousand CAD | -25.68% |
| 2013 | 370.06 Thousand CAD | -0.76% |
| 2012 | 372.9 Thousand CAD | 3.92% |
| 2011 | 358.82 Thousand CAD | 0.64% |
| 2010 | 356.52 Thousand CAD | 12.15% |
| 2009 | 317.88 Thousand CAD | 35.22% |
| 2008 | 235.08 Thousand CAD | 20.37% |
| 2007 | 195.3 Thousand CAD | -97.92% |
| 2006 | 9.4 Million CAD | 20.6% |
| 2005 | 7.8 Million CAD | 103.52% |
| 2004 | 3.83 Million CAD | 110.29% |
| 2003 | 1.82 Million CAD | 13.3% |
| 2002 | 1.6 Million CAD | -26.78% |
| 2001 | 2.19 Million CAD | -15.65% |
| 2000 | 2.6 Million CAD | 0.0% |
| 1999 | - CAD | 0.0% |
| 1998 | - CAD | -100.0% |
| 1997 | 1.00 CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 25.24 Million CAD | -6.2% |
| 2024 Q2 | 29.17 Million CAD | 15.6% |
| 2023 Q3 | 28.21 Million CAD | 28.29% |
| 2023 FY | 101.07 Million CAD | 6.99% |
| 2023 Q4 | 26.9 Million CAD | -4.62% |
| 2023 Q1 | 23.96 Million CAD | -2.89% |
| 2023 Q2 | 21.99 Million CAD | -8.25% |
| 2022 FY | 94.47 Million CAD | 12.7% |
| 2022 Q4 | 24.68 Million CAD | 24.46% |
| 2022 Q3 | 19.83 Million CAD | -27.46% |
| 2022 Q1 | 22.62 Million CAD | -22.83% |
| 2022 Q2 | 27.33 Million CAD | 20.81% |
| 2021 Q3 | 24.49 Million CAD | 17.46% |
| 2021 Q1 | 10 Million CAD | -46.99% |
| 2021 Q4 | 29.31 Million CAD | 19.7% |
| 2021 FY | 83.82 Million CAD | 65.03% |
| 2021 Q2 | 20.85 Million CAD | 108.35% |
| 2020 Q1 | 9.9 Million CAD | 213.85% |
| 2020 FY | 50.79 Million CAD | 508.19% |
| 2020 Q2 | 8.56 Million CAD | -13.54% |
| 2020 Q4 | 18.87 Million CAD | 40.37% |
| 2020 Q3 | 13.44 Million CAD | 57.04% |
| 2019 Q1 | 817 Thousand CAD | 247.66% |
| 2019 FY | 8.35 Million CAD | 1018.07% |
| 2019 Q2 | 2.76 Million CAD | 238.07% |
| 2019 Q3 | 1.61 Million CAD | -41.46% |
| 2019 Q4 | 3.15 Million CAD | 95.18% |
| 2018 Q1 | 618.36 Thousand CAD | -55.13% |
| 2018 Q4 | 235 Thousand CAD | -54.1% |
| 2018 FY | 747 Thousand CAD | -45.79% |
| 2018 Q2 | 282 Thousand CAD | -54.4% |
| 2018 Q3 | 512 Thousand CAD | 81.56% |
| 2017 FY | 1.37 Million CAD | 495.93% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 Q1 | - CAD | -100.0% |
| 2017 Q4 | 1.37 Million CAD | 0.0% |
| 2016 Q2 | 56.08 Thousand CAD | 9.13% |
| 2016 Q4 | 50.62 Thousand CAD | -30.77% |
| 2016 Q1 | 51.39 Thousand CAD | 7.25% |
| 2016 FY | 231.23 Thousand CAD | -10.1% |
| 2016 Q3 | 73.12 Thousand CAD | 30.38% |
| 2015 Q3 | 73.97 Thousand CAD | 4.63% |
| 2015 FY | 257.2 Thousand CAD | -6.49% |
| 2015 Q1 | 64.6 Thousand CAD | -0.94% |
| 2015 Q2 | 70.7 Thousand CAD | 9.43% |
| 2015 Q4 | 47.92 Thousand CAD | -35.22% |
| 2014 Q4 | 65.22 Thousand CAD | -4.22% |
| 2014 FY | 275.05 Thousand CAD | -25.68% |
| 2014 Q2 | 73.11 Thousand CAD | 6.56% |
| 2014 Q1 | 68.61 Thousand CAD | -14.9% |
| 2014 Q3 | 68.09 Thousand CAD | -6.87% |
| 2013 Q4 | 80.62 Thousand CAD | -12.75% |
| 2013 FY | 370.06 Thousand CAD | -0.76% |
| 2013 Q3 | 92.41 Thousand CAD | -7.7% |
| 2013 Q2 | 100.11 Thousand CAD | 3.31% |
| 2013 Q1 | 96.91 Thousand CAD | -1.05% |
| 2012 Q2 | 91.24 Thousand CAD | -1.37% |
| 2012 Q3 | 91.21 Thousand CAD | -0.03% |
| 2012 Q4 | 97.93 Thousand CAD | 7.36% |
| 2012 FY | 372.9 Thousand CAD | 3.92% |
| 2012 Q1 | 92.5 Thousand CAD | 2.72% |
| 2011 Q4 | 90.05 Thousand CAD | -2.71% |
| 2011 Q3 | 92.55 Thousand CAD | 1.66% |
| 2011 Q2 | 91.04 Thousand CAD | 6.91% |
| 2011 Q1 | 85.16 Thousand CAD | -0.18% |
| 2011 FY | 358.82 Thousand CAD | 0.64% |
| 2010 Q3 | 84.91 Thousand CAD | -18.53% |
| 2010 FY | 356.52 Thousand CAD | 12.15% |
| 2010 Q4 | 85.31 Thousand CAD | 0.47% |
| 2010 Q2 | 104.23 Thousand CAD | 27.0% |
| 2010 Q1 | 82.06 Thousand CAD | -0.04% |
| 2009 Q2 | 90.73 Thousand CAD | 46.28% |
| 2009 Q4 | 82.1 Thousand CAD | -1.09% |
| 2009 Q3 | 83.01 Thousand CAD | -8.51% |
| 2009 FY | 317.88 Thousand CAD | 35.22% |
| 2009 Q1 | 62.03 Thousand CAD | 1.02% |
| 2008 FY | 235.08 Thousand CAD | 20.37% |
| 2008 Q4 | 61.4 Thousand CAD | -9.27% |
| 2008 Q1 | 50.68 Thousand CAD | 100.71% |
| 2008 Q2 | 55.31 Thousand CAD | 9.12% |
| 2008 Q3 | 67.68 Thousand CAD | 22.37% |
| 2007 FY | 195.3 Thousand CAD | -97.92% |
| 2007 Q4 | -7.12 Million CAD | -326.8% |
| 2007 Q3 | 3.14 Million CAD | 46.92% |
| 2007 Q2 | 2.13 Million CAD | 4.81% |
| 2007 Q1 | 2.04 Million CAD | -28.73% |
| 2006 FY | 9.4 Million CAD | 20.6% |
| 2006 Q1 | 2.16 Million CAD | -34.94% |
| 2006 Q4 | 2.86 Million CAD | 23.57% |
| 2006 Q2 | 2.06 Million CAD | -4.69% |
| 2006 Q3 | 2.31 Million CAD | 12.41% |
| 2005 Q4 | 3.32 Million CAD | 106.61% |
| 2005 FY | 7.8 Million CAD | 103.52% |
| 2005 Q1 | 1.34 Million CAD | -11.18% |
| 2005 Q3 | 1.6 Million CAD | 5.87% |
| 2005 Q2 | 1.52 Million CAD | 13.01% |
| 2004 Q3 | 861.09 Thousand CAD | 2.48% |
| 2004 FY | 3.83 Million CAD | 110.29% |
| 2004 Q1 | 584.41 Thousand CAD | -14.27% |
| 2004 Q2 | 840.26 Thousand CAD | 43.78% |
| 2004 Q4 | 1.51 Million CAD | 75.94% |
| 2003 Q4 | 681.72 Thousand CAD | 74.26% |
| 2003 Q3 | 391.21 Thousand CAD | 10.76% |
| 2003 Q2 | 353.19 Thousand CAD | -11.03% |
| 2003 Q1 | 397 Thousand CAD | 0.0% |
| 2003 FY | 1.82 Million CAD | 13.3% |
| 2002 FY | 1.6 Million CAD | -26.78% |
| 2002 Q3 | - CAD | -100.0% |
| 2002 Q4 | - CAD | 0.0% |
| 2002 Q1 | 279.96 Thousand CAD | 0.0% |
| 2002 Q2 | 358.28 Thousand CAD | 27.98% |
| 2001 Q1 | 376.08 Thousand CAD | 0.0% |
| 2001 Q3 | - CAD | 0.0% |
| 2001 Q2 | - CAD | -100.0% |
| 2001 Q4 | - CAD | 0.0% |
| 2001 FY | 2.19 Million CAD | -15.65% |
| 2000 Q2 | - CAD | 0.0% |
| 2000 Q1 | - CAD | 0.0% |
| 2000 FY | 2.6 Million CAD | 0.0% |
| 2000 Q3 | - CAD | 0.0% |
| 2000 Q4 | - CAD | 0.0% |
| 1999 FY | - CAD | 0.0% |
| 1999 Q1 | - CAD | 0.0% |
| 1999 Q4 | - CAD | 0.0% |
| 1999 Q2 | - CAD | 0.0% |
| 1999 Q3 | - CAD | 0.0% |
| 1998 Q1 | - CAD | -100.0% |
| 1998 Q2 | - CAD | 0.0% |
| 1998 FY | - CAD | -100.0% |
| 1997 FY | 1.00 CAD | 0.0% |
| 1997 Q4 | 1.00 CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Aurora Cannabis Inc. | 270.28 Million CAD | 62.603% |
| Avicanna Inc. | 16.79 Million CAD | -501.96% |
| Avant Brands Inc. | 26.34 Million CAD | -283.685% |
| Cardiol Therapeutics Inc. | - CAD | -Infinity% |
| Crescita Therapeutics Inc. | 17.52 Million CAD | -476.863% |
| Knight Therapeutics Inc. | 328.19 Million CAD | 69.202% |
| MediPharm Labs Corp. | 33.06 Million CAD | -205.723% |
| OrganiGram Holdings Inc. | 149.2 Million CAD | 32.256% |
| Canopy Growth Corporation | 297.14 Million CAD | 65.984% |
| Willow Biosciences Inc. | 1.17 Million CAD | -8524.403% |